Ignite Creation Date:
2025-12-24 @ 7:32 PM
Ignite Modification Date:
2026-01-01 @ 8:47 AM
Study NCT ID:
NCT02643303
Status:
COMPLETED
Last Update Posted:
2022-12-02
First Post:
2015-12-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
Sponsor:
Ludwig Institute for Cancer Research
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-12-28
Start Date Type:
ACTUAL
Primary Completion Date:
2022-02-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-02-23
Completion Date Type:
ACTUAL
First Submit Date:
2015-12-18
First Submit QC Date:
None
Study First Post Date:
2015-12-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-09-15
Results First Submit QC Date:
None
Results First Post Date:
2022-12-02
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-17
Last Update Post Date:
2022-12-02
Last Update Post Date Type:
ACTUAL